Trials / Sponsors / Knight Therapeutics (USA) Inc
Knight Therapeutics (USA) Inc
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Mucocutaneous Leishmaniasis | — | 2015-12-01 |
| Withdrawn | Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Leishmaniasis | — | 2015-07-01 |
| Withdrawn | Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry Leishmaniasis or Other Uses of Miltefosine | — | 2015-07-01 |
| Completed | Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Mucocutaneous Leishmaniasis | — | 2015-07-01 |
| Completed | Miltefosine to Treat Mucocutaneous Leishmaniasis Mucosal Leishmaniasis, Cutaneous Leishmaniasis | Phase 2 | 2010-05-01 |